In this video from the Macula Society meeting, Theodore Leng, MD, FACS, discusses 5-year data on pegcetacoplan, from Apellis, for geographic atrophy.
“This presentation really supported the notion that earlier and continuous treatment yielded better outcomes for preserving retinal tissue and delaying GA progression in the long term,” Leng, professor of ophthalmology and director of clinical and translational research at Byers Eye Institute, Stanford University, said.